Barclays’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-35,800
Closed -$3.36M 5352
2024
Q3
$3.36M Buy
35,800
+8,800
+33% +$739K ﹤0.01% 2424
2024
Q2
$2.1M Buy
+27,000
New +$2.2M ﹤0.01% 2099

Other funds holding GEHC

Barclays's GEHC Position: Q2 2026 in Review

Barclays reduced its GE HealthCare (GEHC) stake by 50% in Q2 2026, selling an estimated $59.5M and leaving 913,578 shares worth $58.5M. The position accounts for 0.01% of the portfolio, ranked #676.

Barclays first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $260M in Q3 2024. 1,229 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Barclays held 913,578 shares of GE HealthCare worth $58.5M as of Q2 2026.
  • Barclays sold 905,083 GE HealthCare shares in Q2 2026, an estimated $59.5M.
  • GE HealthCare made up 0.01% of Barclays's portfolio in Q2 2026, its #676 holding.
  • Barclays first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Barclays's GE HealthCare position peaked at $260M in Q3 2024.
  • 1,229 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.